Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09WSG
|
||||
Former ID |
DNC008135
|
||||
Drug Name |
Salvinorin B benzyloxymethyl ether
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529133] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H34O8
|
||||
Canonical SMILES |
CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOCC4=CC=CC=C4<br />)C)C5=COC=C5
|
||||
InChI |
1S/C29H34O8/c1-28-11-9-20-27(32)37-23(19-10-12-34-16-19)14-29(20,2)25(28)24(30)22(13-21(28)26(31)33-3)36-17-35-15-18-7-5-4-6-8-18/h4-8,10,12,16,20-23,25H,9,11,13-15,17H2,1-3H3/t20-,21-,22-,23-,25-,28-,29-/m0/s1
|
||||
InChIKey |
UEIIMJAHRTUJMW-ZZIVESEQSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [529133] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.